Cells were either harvested for cell death assessment by AnnexinV-FITC/PI staining or for DEVDase assay analysis
In August 2025, Novo Nordisk announced that the FDA has approved WEGOVY as the first GLP-1 receptor agonist for adults with Metabolic Dysfunction-associated Steatohepatitis (MASH) who have moderate to advanced fibrosis, excluding cirrhosis, in combination with diet and exercise
Not manufactured with yeast, wheat, gluten, soy, milk, egg, fish, shellfish or tree nut ingredients
If youve enrolled in a Medicare Advantage plan and you dont like it, you may think switching Medicare plans and enrolling in Medigap is a great idea
Freshwater snails are the first intermediate hosts, and freshwater fishes belonging to the family Cyprinidae are second intermediate hosts in which larval development occurs